VM

Vipulkumar Mafatlal Patel

Active Director Additional Director DIN 11436949
DIN 11436949 First appointment Dec 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Vipulkumar Mafatlal Patel

Data last updated:

Vipulkumar Mafatlal Patel is an Additional Director at Medtrion Healthcare Private Limited (since 2025).

DIN 11436949
Primary Designation Additional Director
First Appointment 18 Dec 2025

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medtrion Healthcare Private Limited U21001GJ2025PTC167429
Additional Director18 Dec 2025Active

Board colleagues of Vipulkumar Mafatlal Patel

Directorship timeline

Open interactive timeline →
Medtrion Healthcare Private Limited
Premium access

Shareholding and investment profile for Vipulkumar Mafatlal Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vipulkumar Mafatlal Patel

Vipulkumar Mafatlal Patel currently holds 1 directorship: Medtrion Healthcare Private Limited (Additional Director, since 18 Dec 2025).

Vipulkumar Mafatlal Patel was first appointed on 18 Dec 2025 as Additional Director at Medtrion Healthcare Private Limited.

The current boards of Vipulkumar Mafatlal Patel's companies include Chirag Mafatlal Patel (Medtrion Healthcare Private Limited), Kalpesh Prakashchandra Jain (Medtrion Healthcare Private Limited), Niral Mansukhbhai Patel (Medtrion Healthcare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available